{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:43:54Z","timestamp":1763563434870,"version":"3.45.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"DOI":"10.1186\/s42358-025-00501-3","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:36:58Z","timestamp":1763563018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reply to the letter on \u201cBrazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe?\u201d"],"prefix":"10.1186","volume":"65","author":[{"given":"Viviane Angelina","family":"de Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Luiza Mendes Amorim","family":"Caparroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia Fernandes Mo\u00e7a","family":"Trevisani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Carolina Faria Moreira Gomes","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Karla Guedes","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anete","family":"Trajman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Cristina","family":"de Medeiros-Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"de Medeiros Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo Machado","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odirlei Andre","family":"Monticielo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Fernanda Brand\u00e3o","family":"de Resende Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavio","family":"Sztajnbok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidney","family":"Bombarda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana Andrade","family":"Chebli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana Maria","family":"Kakehasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Luiza","family":"Bierrenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula Monteiro Gomides","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca Elena Rios Gomes","family":"Bica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Diniz Lopes","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise Silva","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo dos Santos","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana Dias","family":"Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Dockhorn Costa","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helio Arthur","family":"Bacha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana Starling","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Roberto","family":"Provenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketty Lysie Libardi Lira","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Licia Maria Henrique","family":"da Mota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian David","family":"de Azevedo Valadares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Ant\u00f4nio Ara\u00fajo","family":"da Rocha Loures","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margareth Maria Pretti","family":"Dalcolmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cecilia","family":"de Carvalho Bortoletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max Igor Banks Ferreira","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rejane Maria Rodrigues","family":"de Abreu Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Romiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogerio","family":"Saad-Hossne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rozana Mesquita","family":"Ciconelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valderilio Feij\u00f3","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9ria Maria","family":"Augusto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitor Alves","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gecilmara Cristina Salviato","family":"Pileggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"501_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-025-00462-7","author":"C Brito","year":"2025","unstructured":"Brito C, De Brito RM. Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe? Adv Rheumatol. 2025. https:\/\/doi.org\/10.1186\/s42358-025-00462-7.","journal-title":"Adv Rheumatol"},{"key":"501_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s42358-025-00449-4","volume":"65","author":"VA de Souza","year":"2025","unstructured":"de Souza VA, Caparroz ALMA, Trevisani VFM, Gomes Tavares ACFM, de Melo AKG, Trajman A. et. al. Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases. Adv Rheumatol. 2025;65:18. https:\/\/doi.org\/10.1186\/s42358-025-00449-4.","journal-title":"Adv Rheumatol"},{"key":"501_CR3","unstructured":"BRASIL. Minist\u00e9rio da Sa\u00fade. Boletim Epidemiol\u00f3gico de Tuberculose 2025. Bras\u00edlia: Secretaria de Vigil\u00e2ncia em Sa\u00fade e Ambiente. 2025. Dispon\u00edvel em: https:\/\/www.gov.br\/saude\/pt-br\/composicao\/svsa\/boletins-epidemiologicos. Acesso em: 9 jul. 2025."},{"key":"501_CR4","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/ard-2022-223335","volume":"82","author":"GE Fragoulis","year":"2023","unstructured":"Fragoulis GE, Nikiphorou E, Dey M, Zhao SS, Courvoisier DS, Arnaud L. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2023;82:742\u201353. https:\/\/doi.org\/10.1136\/ard-2022-223335.","journal-title":"Ann Rheum Dis"},{"key":"501_CR5","unstructured":"ORGANIZA\u00c7\u00c3O MUNDIAL DE SA\u00daDE. WHO consolidated guidelines on tuberculosis. Module 1: prevention \u2013 tuberculosis preventive treatment. 2024, segunda edi\u00e7\u00e3o. Disponivel em: https:\/\/www.who.int\/publications\/i\/item\/9789240096196. Acesso: 13 jul. 2025."},{"key":"501_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3201\/eid1205.050681","volume":"12","author":"ME Balcells","year":"2006","unstructured":"Balcells ME, Thomas SL, Godfrey-Frazier L, Grant AD. Isoniazid preventive therapy and risk for resistant tuberculosis: a systematic review and meta-analysis. Emerg Infect Dis. 2006;12:744\u201351. https:\/\/doi.org\/10.3201\/eid1205.050681.","journal-title":"Emerg Infect Dis"},{"key":"501_CR7","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.5588\/ijtld.15.0908","volume":"20","author":"S Den Boon","year":"2016","unstructured":"Den Boon S, Matteelli A, Getahun H. Rifampicin resistance after treatment for latent tuberculous infection: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2016;20:1065\u201371. https:\/\/doi.org\/10.5588\/ijtld.15.0908.","journal-title":"Int J Tuberc Lung Dis"},{"key":"501_CR8","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S0140-6736(24)02479-6","volume":"405","author":"A Trajman","year":"2025","unstructured":"Trajman A, Campbell JR, Kunor T, Ruslami R, Amanullah F, Behr M. et. al. Tuberculosis. Lancet Seminars. 2025;405:850\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(24)02479-6.","journal-title":"Lancet Seminars"},{"key":"501_CR9","doi-asserted-by":"publisher","unstructured":"Martinez L, Seddon JA, Horsburgh R, Lange C, Mandalakas AM, TB Contact Studies Consortium. Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies. Lancet Respir Med. 2024:633\u201341. https:\/\/doi.org\/10.1016\/S2213-2600(24)00083-3.","DOI":"10.1016\/S2213-2600(24)00083-3"},{"issue":"8","key":"501_CR10","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s10067-017-3714-6","volume":"36","author":"G Garziera","year":"2017","unstructured":"Garziera G, Morsch ALB, Otesbelgue F, Staub FL, Palominos PE, Brenol CV. et. Al. Latent tuberculosis infection and tuberculosis in patients with rheumatic diseases treated with anti-tumor necrosis factor agents. Clin Rheumatol. 2017;36(8):1891\u20136. https:\/\/doi.org\/10.1007\/s10067-017-3714-6. Epub 2017 Jun 6. PMID: 28589321.","journal-title":"Clin Rheumatol"},{"key":"501_CR11","unstructured":"NOTA INFORMATIVA N\u00ba 4\/2024-CGTM\/.DATHI\/SVSA\/MS. Recomenda\u00e7\u00f5es t\u00e9cnicas aos enfermeiros para orientar a indica\u00e7\u00e3o do tratamento da Infec\u00e7\u00e3o Latente da Tuberculose (ILTB), os algoritmos para idenfica\u00e7\u00e3o e rastreio da ILTB, al\u00e9m de recomenda\u00e7\u00f5es sobre o tratamento da infec\u00e7\u00e3o latente pelo Mycobacterium tuberculosis. Dispon\u00edvel em https:\/\/www.gov.br\/aids\/pt-br\/central-de-conteudo\/notas-informativas\/2024\/nota-informativa-no-42024-cgtm-dathisvsa.pdf. Acesso em 26 de agosto de 2025."},{"issue":"7","key":"501_CR12","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1590\/0074-02760150235","volume":"110","author":"CMF Gomes","year":"2015","unstructured":"Gomes CMF, Terreri MT, de Moraes-Pinto MI, Barbosa C, Machado NP, Melo MR. Incidence of active mycobacterial infections in Brazilian patients with chronic inflammatory arthritis and negative evaluation for latent tuberculosis infection at baseline - A longitudinal analysis after using TNF\u03b1 blockers. Mem Inst Oswaldo Cruz. 2015;110(7):921\u20138.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"501_CR13","doi-asserted-by":"publisher","first-page":"e1870","DOI":"10.6061\/clinics\/2020\/e1870","volume":"75","author":"AY Shimabuco","year":"2020","unstructured":"Shimabuco AY, de Medeiros-Ribeiro AC, Miossi R, Bonfiglioli KR, de Moraes JCB, Gon\u00e7alves CR. Ankylosing spondylitis and psoriatic arthritis: revisiting screening of latent tuberculosis infection and its follow-up during anti-tumor necrosis factor therapy in an endemic area. Clin (Sao Paulo). 2020;75:e1870.","journal-title":"Clin (Sao Paulo)"},{"key":"501_CR14","doi-asserted-by":"publisher","unstructured":"Mow WS, Abreu-Martin MT, Papadakis KA, Pitchon HE, Targan SR, Vasiliauskas EA. High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy. Clin Gastroenterol Hepatol. 2004;2(4):309\u2009\u2013\u200913. https:\/\/doi.org\/10.1016\/s1542-3565(04)00060-6. PMID: 15067625.","DOI":"10.1016\/s1542-3565(04)00060-6"},{"key":"501_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s42358-024-00406-7","volume":"64","author":"V de Oliveira Magalh\u00e3es","year":"2024","unstructured":"de Oliveira Magalh\u00e3es V, Bonfiglioli KR, Gomes CMF, Bonf\u00e1 E, de Medeiros-Ribeiro AC, Saad CS. Tuberculin skin test repetition after TNF-\u03b1 inhibitors in patients with chronic inflammatory arthritis: a long-term retrospective cohort in endemic area. Adv Rheumatol. 2024;64:70. https:\/\/doi.org\/10.1186\/s42358-024-00406-7.","journal-title":"Adv Rheumatol"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00501-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-025-00501-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00501-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:37:00Z","timestamp":1763563020000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-025-00501-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["501"],"URL":"https:\/\/doi.org\/10.1186\/s42358-025-00501-3","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was carried out in the absence of any commercial or financial relationship that could be interpreted as a potential conflict of interest. Several authors of these guidelines, including voting members, have interacted with the pharmaceutical industry including the manufacturers of some of the drugs mentioned in these recommendations. However, none of the authors received any support or fee directly or indirectly related to or influencing the development of these guidelines. AKGM received speaker fees and consulting from Abbvie, Johnson & Johnson. AMK received consuting fees from Abbvie, Lilly, UCB, Organon, and Janssen. CF received speaker fees from Takeda, Janssen, Abbvie, Amgen, Organon. ESP received speaker fees and consulting from Abbvie, Novartis, Lilly, Johnson & Johnson. JSC received speaker fees from GSK and Janssen. KLLLM received speaker fees and consulting from Novartis and Johnson & Johnson. LAC received speaker fees and consulting from Johnson & Johnson, Takeda, Abbvie. LDAV received speaker fees and consulting from Novartis, Johnson & Johnson. LMHM received speaker fees and consulting from Johnson & Johnson, Abbvie, Pfizer, Novartis, Amgen, Organon, Celltrion, UCB. MFBRG received speaker fees and consulting from Johnson & Johnson, Abbvie, Amgen, Lilly, UCB. MIBFL received speaker fees and consulting from Abbvie, Novartis, Takeda, Johnson & Johnson. MMP received consuting fees from Abbvie, Lilly and Janssen. RMX received Speaker fees, consulting, research funding from Abbvie, Pfizer, Amgen, Biogen, Novartis, Janssen, UCB. RR is\/has served as a scientific consultant, speaker, or clinical study investigator for AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Galderma, Janssen-Cilag, Eli-Lilly, Leo-Pharma, Novartis, Pfizer, Sanofi, and UCB. RSH received speaker fees and consulting from Abbvie, Novartis, Takeda, Johnson & Johnson. OAM received consulting fees from AstraZeneca and GSK; received payment or honoraria for lectures or presentations from AbbVie, Janssen, GSK, UCB and AstraZeneca; and participated in a data safety monitoring board or advisory board for GSK, CellTrion, Bristol, Novartis, Janssen, and AstraZeneca. VAS received speaker fees and consulting from Abbvie, Novartis, Lilly, Johnson & Johnson, GSK, Astrazeneca. VFA received speaker fees, consulting, clinical researches from Celltiron, Amgen, Janssen, Organon, Sandoz, Abbvie, Fresenius Kabi, Takeda, LG, Boehringer-Ingelheim, Bristol Myers-Squibb, GSK, AstraZeneca. Eduardo dos Santos Paiva is Co-EiC of Advances in Rheumatology. Ana Karla Guedes de Melo, Ana Cristina de Medeiros Ribeiro and Marcelo de Medeiros Pinheiro are Associate Editors of the journal Advances in Rheumatology; Ricardo Machado Xavier is a Consulting editor of the journal; Adriana Maria Kakehasi and Licia Maria Henrique da Mota are members of the editorial board of this journal. The peer-review of this paper was therefore overseen by an independent member of the editorial board while the submission was subject to the exact same review process as applied to any other manuscript.The authors not mentioned above declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}